Intervention Protocol

You have free access to this content

Antibiotics for secondary prevention of coronary heart disease

  1. Maria Skoog1,*,
  2. Berit Grevstad1,
  3. Jørn Wetterslev1,
  4. Asbjørn Hróbjartsson2,
  5. Christian Gluud3

Editorial Group: Cochrane Heart Group

Published Online: 28 FEB 2013

DOI: 10.1002/14651858.CD003610.pub2


How to Cite

Skoog M, Grevstad B, Wetterslev J, Hróbjartsson A, Gluud C. Antibiotics for secondary prevention of coronary heart disease (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD003610. DOI: 10.1002/14651858.CD003610.pub2.

Author Information

  1. 1

    Rigshospitalet, Copenhagen University Hospital, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Copenhagen, Denmark

  2. 2

    Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

  3. 3

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Maria Skoog, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. MS@ctu.dk.

Publication History

  1. Publication Status: Amended to reflect a change in scope (see 'What's new')
  2. Published Online: 28 FEB 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the beneficial and harmful effects of antibiotics given as secondary prevention to patients with CHD.